SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), a late stage developer of oncology and DNA vaccines using electroporation to deliver drugs and nucleic acids, announced today that the Company’s Associate Vice President, Dennis D’Oria, will present a corporate overview on Inovio at the BIO-Europe 12th Annual International Partnering Conference, Tuesday, November 7th, at 14:00 European Central Time in Room 28, Level 2, at the Congress Center Duesseldorf in Duesseldorf, Germany.
